Research update – ProQR
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
Search
Search results
Get involved
Our community are the reason we are able to continue supporting those with inherited sight-loss conditions through research and practical support.
Volunteering FAQs
These are some of the most commonly asked questions about volunteering for our charity.
From isolation to exploration: what you can do to build your confidence when travelling
During Loneliness Awareness Week, we're hosting a special webinar to address the challenges faced by individuals with sight loss when it comes to travel and mobility.
Fundraising FAQs
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.
10 For 10 Virtual Challenge
Take on a challenge with #TeamRetinaUK! Run, jog or walk 10 miles in your neighbourhood.
jCyte update
In spring 2021, the US company jCyte announced detailed results from their successful phase 2b clinical trial of jCell, a stem cell-based treatment for RP.